Rybelsus, a novel medication approved for managing Type 2 diabetes, stands out in the diabetes treatment landscape. This oral medication, which utilizes the active ingredient semaglutide, works effectively by mimicking the action of glucagon-like peptide-1 (GLP-1). GLP-1 plays a pivotal role in regulating blood sugar levels, particularly after meals. By…